FDx Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

FDx Advisors’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,099	Closed	-$222K	–	826
2022 Q2	$222K	Buy	3,099 +583	+23%	+$42.6K	0.01%	741
2022 Q1	$204K	Sell	2,516 -6,289	-71%	-$532K	0.01%	793
2021 Q4	$904K	Sell	8,805 -189	-2%	-$18.1K	0.03%	382
2021 Q3	$787K	Buy	+8,994	New	+$814K	0.03%	386
2021 Q2	–	Sell	-6,663	Closed	-$505K	–	870
2021 Q1	$505K	Buy	6,663 +77	+1%	+$5.8K	0.02%	468
2020 Q4	$449K	Buy	+6,586	New	+$411K	0.02%	462

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FDx Advisors's SYNH Position: Q3 2022 in Review

FDx Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 3,099 shares — an estimated $222K sold.

FDx Advisors first reported a position in SYNH in Q4 2020 and held it in 6 quarters. The position peaked at $904K in Q4 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

FDx Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
FDx Advisors sold 3,099 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $222K.
FDx Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
FDx Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $904K in Q4 2021.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on FDx Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.